BioPorto A/S
CPH: BIOPOR.CO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Copenhagen
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Carsten Buhl
- Employees
- 48
- Headquarters
- Hellerup, Denmark
- IPO year
- 2000
- Market cap
- DKK 569.4M
- Website
- https://bioporto.com
Loading BIOPOR…
Loading profile data…Frequently asked questions about BIOPOR
What does BioPorto A/S (BIOPOR.CO) do?
BioPorto A/S, an in-vitro diagnostics company, provides biomarker tests and tools, and antibodies for clinicians and researchers in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated chemistry anal...
Where does BIOPOR.CO trade?
BioPorto A/S (BIOPOR.CO) trades on the NASDAQ Copenhagen.
What sector is BIOPOR.CO in?
BioPorto A/S (BIOPOR.CO) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of BioPorto A/S?
Carsten Buhl is the chief executive officer of BioPorto A/S (BIOPOR.CO).
Where is BioPorto A/S headquartered?
BioPorto A/S is headquartered in Denmark.
Does BIOPOR.CO pay a dividend?
BioPorto A/S (BIOPOR.CO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIOPOR.CO go public?
BioPorto A/S (BIOPOR.CO) completed its initial public offering in 2000.